Pfützner, A., Schöndorf, T., Hanefeld, M., & Forst, T. (2010). High-Sensitivity C-Reactive Protein Predicts Cardiovascular Risk in Diabetic and Nondiabetic Patients: Effects of Insulin-Sensitizing Treatment with Pioglitazone. Diabetes Technology Society.
Citação norma ChicagoPfützner, Andreas, Thomas Schöndorf, Markolf Hanefeld, and Thomas Forst. High-Sensitivity C-Reactive Protein Predicts Cardiovascular Risk in Diabetic and Nondiabetic Patients: Effects of Insulin-Sensitizing Treatment With Pioglitazone. Diabetes Technology Society, 2010.
MLA CitationPfützner, Andreas, Thomas Schöndorf, Markolf Hanefeld, and Thomas Forst. High-Sensitivity C-Reactive Protein Predicts Cardiovascular Risk in Diabetic and Nondiabetic Patients: Effects of Insulin-Sensitizing Treatment With Pioglitazone. Diabetes Technology Society, 2010.